Two bracket fungi, unrelated beyond growing on wood. Turkey tail forms thin, flexible, banded fans with no stem. Reishi forms a heavy shelf with a varnished surface. Once either has been dried, milled and extracted, no feature survives that would let anyone confirm the species by eye. DNA barcoding of the internal transcribed spacer region does confirm it, and the published work notes it is hardest to apply to mycelium, precisely because processing strips away the characters taxonomists rely on.
Part used is the quality variable this category leaves unstated. A fruiting body extract and mycelium grown on a grain substrate are different raw materials entirely. The grain brings starch with it, starch is an alpha-glucan, and alpha-glucan sits inside any figure described as total polysaccharide. Both species enter the Endoca range as fruiting body extracts.
A certificate of analysis settles identity, glucan fractions, heavy metals, pesticide residues and microbial load for one batch of finished extract. What it will not tell you is how a polysaccharide fraction behaves in a person, and nothing printed on a COA bridges that gap.
Nobody weighs beta-glucan. The established approach hydrolyses total glucan with sulfuric acid and quantifies the glucose released, then quantifies alpha-glucan separately by digesting starch and glycogen with glucoamylase, and arrives at beta-glucan by subtraction. Starch carried over from a growing substrate pushes the total up, so the final beta-glucan figure is meaningful only if that starch was subtracted.
Reishi is awkward in its own right. In the validation work for this approach, Ganoderma lucidum and Poria cocos returned significantly higher beta-glucan values after sulfuric acid hydrolysis than after hydrochloric, while most other species gave the same answer either way. The Congo red assay, which responds to the intact triple helix rather than to released glucose, produces a third set of figures. Reviews of mushroom glucans state plainly that values are comparable only when the same method produced them.
Solubility then separates the two species. The turkey tail fractions studied are water soluble, so hot water is the step that matters. Reishi holds two classes of compound that behave in opposite ways: beta-glucans come out in hot water, ganoderic acids need alcohol. A single-solvent reishi extract leaves one of the two behind.
These are two kinds of dataset, not two scores on one scale. The turkey tail figures describe PSK, a standardised preparation given inside cancer treatment. The reishi figures describe reishi, and the two most clearly reported endpoints came back null.
Work from what the label can be held to. Look for the Latin name, for the part used stated as fruiting body, and for a glucan figure that names its method. Where a turkey tail product points at colorectal or gastric survival figures, those belong to PSK inside cancer treatment and do not carry across. Where reishi is the interest and triterpenoids are the reason, a water-only extract will not contain them. Anyone on chemotherapy, taking tamoxifen or living with liver disease should discuss either species with their clinician first.
Only what has been measured. Turkey tail and reishi are sold as food supplements, and no health claim for either species has been authorised under Regulation (EC) No 1924/2006 as retained in Great Britain law. A seller may not state or imply that either does anything for immunity, recovery or any body function, however carefully the sentence is phrased.
What may be stated is factual composition: species, part used, extraction solvent, milligrams per serving and batch analysis. Citing a PSK trial next to a turkey tail capsule is a claim by implication.
Extracts of these species fall under Regulation (EU) 2015/2283 on novel foods as retained in Great Britain law, which turns on history of consumption in the territory before 15 May 1997. A dried mushroom with a long food history and a concentrated extract of it are not automatically in the same position, and the burden of showing which applies sits with the seller.
Reishi also carries a documented hepatic signal: a fatal case of fulminant hepatitis was reported in a patient taking Ganoderma lucidum as a powder, alongside an earlier case, both having previously taken boiled lingzhi without incident. In female rats, a Trametes versicolor polysaccharide peptide extract lengthened time to peak tamoxifen concentration by 228 percent, a rodent result but one relevant to anyone on endocrine treatment.
Each batch of the Organic Mushroom Immune Complex and the Red Reishi Mushroom Extract is tested by a third-party laboratory, with the certificate of analysis published through the lab portal. A COA establishes identity, heavy metals, pesticide residues and microbial load for a finished extract. It cannot establish what a fraction does in a person, and a batch figure is not evidence for a trial endpoint. Endoca has worked from its own farm, own land and own extraction since 2010.
Turkey tail, though the data describe PSK rather than a retail extract. More than 10,000 randomised participants appear in the PSK literature, all within cancer treatment. Reishi’s randomised record is five cancer trials rated generally unsatisfactory, with no survival reporting at all.
No. PSK is a defined protein-bound polysaccharide preparation supplied within medical practice. Retail Trametes versicolor products are commonly not standardised, and no study has compared the two at a matched dose, so no PSK result reads across to a capsule.
Because the figure depends on the method. Beta-glucan is calculated by subtracting alpha-glucan from total glucan, and Ganoderma lucidum returns higher values after sulfuric acid hydrolysis than after hydrochloric. The Congo red assay gives different numbers again, so percentages are comparable only within one method.
The endpoints did not move. Five trials were eligible and three supplied usable data, all in type 2 diabetes at 1.4 to 3 grams daily for 12 to 16 weeks. HbA1c did not shift across 130 participants, nor did total cholesterol, LDL cholesterol or body mass index across 107.
Sakamoto J, Morita S, Oba K, et al. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomised controlled clinical trials. Cancer Immunol Immunother. 2006;55(4):404-411.
Ma Y, Wu X, Yu J, et al. Can polysaccharide K improve therapeutic efficacy and safety in gastrointestinal cancer? A systematic review and network meta-analysis. Oncotarget. 2017;8(51):89108-89118.
Torkelson CJ, Sweet E, Martzen MR, et al. Phase 1 clinical trial of Trametes versicolor in women with breast cancer. ISRN Oncol. 2012;2012:251632.
Jin X, Ruiz Beguerie J, Sze DM, Chan GC. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev. 2016;4(4):CD007731.
Klupp NL, Chang D, Hawke F, et al. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors. Cochrane Database Syst Rev. 2015;2015(2):CD007259.
McCleary BV, Draga A. Measurement of beta-glucan in mushrooms and mycelial products. J AOAC Int. 2016;99(2):364-373.
Vetter J. The mushroom glucans: molecules of high biological and medicinal importance. Foods. 2023;12(5):1009.
Raja HA, Baker TR, Little JG, Oberlies NH. DNA barcoding for identification of consumer-relevant mushrooms: a partial solution for product certification? Food Chem. 2017;214:383-392.
Wanmuang H, Leopairut J, Kositchaiwat C, et al. Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder. J Med Assoc Thai. 2007;90(1):179-181.
Razmovski-Naumovski V, Kimble B, Laurenti D, et al. Polysaccharide peptide extract from Coriolus versicolor increased Tmax of tamoxifen in the rat. Front Pharmacol. 2022;13:857864.
Regulation (EC) No 1924/2006 on nutrition and health claims made on foods, and Regulation (EU) 2015/2283 on novel foods, both as retained in Great Britain law.
Last reviewed 1 October 2026.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.